equipment in line with the import of capital goods which partly stemmed from the relocation of the manufacturing base of hard disk drive to Thailand earlier. Meanwhile, public spending in capital expenditure
%YoY mainly from spectrum license acquisition and network expansion. • Regulatory fee was Bt5,320mn, flat YoY aligned with core service revenue with representing a stable ratio at 4.1% as FY20
Rule”). Currently, the Company focus on the business expansion of the crude palm oil (CPOA) trading business for biodiesel as there is a high potential growth and will partially conducting a trading CPOA
2018. This was a result of a decline in merchandise exports owing to the economic slowdown of trading partners affected by trade protectionism and the impact of structural changes in the manufacturing
Pte. Limited, paid for share capital totaling AUD 15 million or equivalent to Baht 342.97 million, in the proportion of investment of 100 percent. 1.3 The Expansion of Electricity and Steam Generation
Netherlands due to delay in the brownfield expansion, further reduction in PET and PTA production in the Netherlands (FM in 4Q18), unplanned shutdown in Poland (PET 4Q18), further normalization of IPA margin
manufacturing cosmeceuticals and modern medicine from FDA and controlled quality and operational efficiency which certified by international standards ISO 9001:2008, GMP, PICS, HACCP และ HALAL. Presently, At-Ze
located in Muang district, Chachoengsao province and authorized manufacturing cosmeceuticals and modern medicine from FDA and controlled quality and operational efficiency which certified by international
, At-Ze distributed medical care products under brand name “Aesthetic Zecret”. Factory is located in Muang district, Chachoengsao province and authorized manufacturing cosmeceuticals and modern medicine